D500

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Rauber, C. ; Roberti, M. P.DKFZ* ; Vehreschild, M. J. ; Tsakmaklis, A. ; Springfeld, C. ; Teufel, A. ; Ettrich, T. ; Jochheim, L. ; Kandulski, A. ; Missios, P. ; Mohr, R. ; Reichart, A. ; Waldschmidt, D. T. ; Sauer, L. D. ; Sander, A. ; Schirmacher, P. ; Jäger, D.DKFZ* ; Michl, P. ; Dill, M. (Last author)DKFZ*
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial).
BMJ open 15(9), e097802 (2025) [10.1136/bmjopen-2024-097802]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Editorial) Olkus, A. (First author)DKFZ* ; Dill, M. (Last author)DKFZ*
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial.
Hepatobiliary surgery and nutrition 14(4), 676 - 679 (2025) [10.21037/hbsn-2025-316]2025     Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Rodriguez, I. ; Vellala, A. ; Itzel, T. ; Daza, J. ; Vácha, M. ; Chang, D.-H. ; Debic, M. ; Dill, M.DKFZ* ; Seidensticker, M. ; Mayerle, J. ; Munker, S. ; Schoenberg, S. ; Müller, L. ; Galle, P. ; Weinmann, A. ; Tamandl, D. ; Pinter, M. ; Scheiner, B. ; Weiss, C. ; Pech, M. ; Sinner, F. ; Keitel, V. ; Venerito, M. ; Ebert, M. ; Teufel, A. ; Froelich, M.
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab
Oncology letters 30(4), 484 (2025) [10.3892/ol.2025.15229]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Köhrer, S. ; Sauer, P. ; Dill, M. (Last author)DKFZ*
Diagnostics of biliary tract cancer. [Diagnostik des biliären Karzinoms].
Die Gastroenterologie 20, 214–222 (2025) [10.1007/s11377-025-00908-w]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Ben Khaled, N. ; Zarka, V. ; Hobeika, B. ; Schneider, J. ; Rau, M. ; Weich, A. ; Leicht, H. B. ; Ye, L. ; Piseddu, I. ; Dill, M. T.DKFZ* ; Kandulski, A. ; Pinter, M. ; Ehmer, U. ; Schirmacher, P. ; Marquardt, J. U. ; Mayerle, J. ; De Toni, E. N. ; Geier, A. ; Reiter, F. P.
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort.
Alimentary pharmacology & therapeutics 61(11), 1755-1766 (2025) [DOI:10.1111/apt.70090]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Wei, N. ; Mathy, R. M. ; Chang, D.-H. ; Mayer, P. ; Liermann, J. ; Springfeld, C. ; Dill, M.DKFZ* ; Longerich, T. ; Lurje, G. ; Kauczor, H.-U. ; Wielpütz, M. O. ; Öcal, O.
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.
Cancer imaging 25(1), 104 (2025) [10.1186/s40644-025-00926-5]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Editorial) Dill, M. (First author)DKFZ* ; Tchorz, J. S.
SRChing for new targets in HCC.
Hepatology 82(6), 1408-1410 (2025) [10.1097/HEP.0000000000001285]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Hoffmeister-Wittmann, P. ; Hoegen-Saßmannshausen, P.DKFZ* ; Wicklein, L. ; Weykamp, F.DKFZ* ; Seidensaal, K. ; Springfeld, C. ; Dill, M.DKFZ* ; Longerich, T. ; Schirmacher, P. ; Mehrabi, A. ; Mathy, R. M. ; Köhler, B. C. ; Debus, J.DKFZ* ; Herfarth, K. ; Liermann, J.
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer.
Radiation oncology 20(1), 23 (2025) [10.1186/s13014-025-02594-y]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Mitzlaff, K. ; Kirstein, M. M. ; Müller, C. ; Venerito, M. ; Olkus, A. ; Dill, M. T.DKFZ* ; Weinmann, A. ; Kocheise, L. ; Busch, A. ; Schulze, K. ; Allo, G. ; Waldschmidt, D.-T. ; Barsch, M. ; Bengsch, B. ; Quante, M. ; Gonzalez-Carmona, M. A. ; Himmelsbach, V. ; Finkelmeier, F. ; Kloeckner, R. ; Schirmacher, P. ; Marquardt, J. U. ; Zimpel, C.
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort.
United european gastroenterology journal 12(9), 1230-1242 (2024) [10.1002/ueg2.12656]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Xu, K. ; Kessler, A. ; Nichetti, F. (First author)DKFZ* ; Hoffmeister-Wittmann, P. ; Scherr, A.-L. ; Nader, L. ; Kelmendi, E. ; Schmitt, N. ; Schwab, M. ; García-Beccaria, M.DKFZ* ; Sobol, B. ; Nieto, O. A. ; Isele, H. ; Gärtner, U. ; Vaquero-Siguero, N.DKFZ* ; Volk, J.DKFZ* ; Korell, F.DKFZ* ; Mock, A.DKFZ* ; Heide, D.DKFZ* ; Ramadori, P.DKFZ* ; Lenoir, B.DKFZ* ; Albrecht, T. ; Hüllein, J.DKFZ* ; Jäger, D.DKFZ* ; Fröhling, S.DKFZ* ; Springfeld, C. ; Jackstadt, R.-F.DKFZ* ; Heikenwälder, M.DKFZ* ; Dill, M.DKFZ* ; Roessler, S. ; Goeppert, B. ; Köhler, B. C.DKFZ*
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.
Liver international 44(11), 2950-2963 (2024) [10.1111/liv.16069]2024     Files BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS |